GMED vs WEX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
GMED
WEX
Investment Advisor Scores
WEX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | GMED | WEX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 17.9211 | 9.4787 | WEX |
| PEG Ratio | 1.7253 | 1.053 | WEX |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 27.0% | 14.2% | GMED |
| Earnings Growth | 66.7% | 57.1% | GMED |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 50.7/100 | 49.2/100 | GMED |
| Profit Margin | 18.9% | 12.6% | GMED |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
GMED
NeutralMixed signals - no dominant trend phase, RSI 55
WEX
MarkupPrice above SMA50, rising 50-day trend (6.2% over 20 days), RSI 74
Fundamentals Snapshot
| Metric | GMED | WEX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 15.8 | 8.9 |
| Trailing P/E | 18.4 | 18.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.1% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | 0.2% | 0.3% |
| EPS | 4.28 | 10.02 |
| Dividend Yield | — | — |